Loading
Universities and cancer centres would change how they promote scientists, giving credit for finishing trials, sharing data, replicating others' work and publishing failures, not just for papers in famous journals.
Cancer centres and medical schools adopt narrative CVs and explicit promotion criteria that credit trial completion and reporting, data and code deposition, registered reports, replication studies, tool and model contributions and patient-facing outputs, while discounting journal impact factor (per the San Francisco Declaration on Research Assessment). Funders reinforce this by requiring the same formats in applications. The current system rewards novel positive findings in high-impact journals, which is precisely the incentive structure that produces irreproducible preclinical cancer biology and unpublished trials.
Shares Scoop protection and co-publication norms to reduce academic secrecy, Funder bonuses for releasing results and data within six months, negatives included.
Shares Pay investigators for finishing and publishing trials, not for enrolling patients, Incentives reward me-too drugs and marginal gains.
Shares Preclinical results do not reproduce, Failures are hidden.
Shares Preclinical results do not reproduce, Incentives reward me-too drugs and marginal gains.
Shares Preclinical results do not reproduce, Failures are hidden.
Shares Preclinical results do not reproduce, Failures are hidden.
Shares Preclinical results do not reproduce, Failures are hidden.
Shares Preclinical results do not reproduce, Failures are hidden.